HKU Scholars Hub: Browsing DSpace

Browsing by Author Sukeepaisarnjaroen, W

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 12 to 15 of 15 < previous

	Title	Author(s)	Issue Date	Views
	Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B Journal:Hepatology Communications	Yuen, MF Berliba, E Sukeepaisarnjaroen, W Ahn, SH Tanwandee, T Lim, YS Kim, YJ Poovorawan, K Tangkijvanich, P Schwabe, C Eley, T Brown, J Lee, ACH Thi, EP Paratala, B Mani, N Sofia, MJ Picchio, G Sims, KD Gane, EJ	4-Oct-2022
	Safety, tolerability, pharmacokinetics (PK), and antiviral activity of the capsid inhibitor (CI) AB-506 in healthy subjects (HS) and chronic hepatitis B (CHB) subjects Proceeding/Conference:Hepatology	Yuen, RMF Berliba, E Sukeepaisarnjaroen, W Ahn, SH Tanwandee, T Lim, Y-S Kim, YJ Poovorawan, K Tangkijvanich, P Chan, HLY Eley, T Brown, J Moore, C Lee, ACH Kim, J Thi, EP Mani, N Rijnbrand, R Cole, A Sofia, MJ Picchio, GR Sims, K Gane, EJ	2019	48
	The pharmacokinetic and safety profiles of RO7445482 SIRNA are similar between Asian and nonAsian healthy volunteers and chronic hepatitis B patients in a phase 1 Study Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Gane, EJ Guerreiro, N Buatois, S Kim, W Yoon, J-H Lim, TH Siever, W Thompson, A Sukeepaisarnjaroen, W Tangkijvanich, P Schwabe, C Brown, BD Triyatni, M Bo, QY Achneck, H Yuen, RMF	2021
	Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study Journal:JHEP Reports	Ma, HY Lim, TH Leerapun, A Wellman, M Jia, JD Lim, Y-S Tangkijvanich, P Sukeepaisarnjaroen, W Ji, Y Le Bert, N Li, D Zhang, Y Hamatake, R Tan, N Li, CM Strasser, SI Ding, HG Yoon, J-H Stace, NH Ahmed, T Anderson, DE Yan, L Bertoletti, A Zhu, Q Yuen, RMF	2021

Showing results 12 to 15 of 15 < previous